The American Journal of Hematology provides broad coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease. The journal publishes original contributions in non-malignant and malignant hematological diseases including clinical and basic studies in hemostasis and thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports describing novel therapeutic approaches to diagnosis and treatment of hematological diseases are welcomed and encouraged. The journal includes regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, letters and correspondence.
《美国血液学杂志》广泛报道了人类和人类疾病动物模型中血液疾病的实验和临床特征。该杂志发表非恶性和恶性血液病的原创论文，包括止血和血栓形成、免疫学、血库和干细胞生物学的临床和基础研究。欢迎并鼓励临床转化报告描述诊断和治疗血液疾病的新治疗方法。该杂志包括定期原始实验室和临床研究文章，简短的研究报告，评论，血液学图像，信件和通信。
Chimeric antigen receptor T cell immunotherapy for multiple myeloma: A review of current data and potential clinical applications
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25428
Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: “2019 Update on Diagnosis, Risk‐stratification, and Management”
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25397
Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25444
Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25459
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25566
White matter has impaired resting oxygen delivery in sickle cell patients
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25423
Drug‐induced thrombocytopenia: 2019 Update of clinical and laboratory data
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25379
Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25493
Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B‐cell malignancies: Results of a phase I study
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25387
Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25634
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25296
Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25395
Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25302
Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25666
Changes in health‐related quality of life with long‐term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25348
Eligibility for CAR T‐cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25411
Shortening the ex vivo culture of CD19‐specific CAR T‐cells retains potent efficacy against acute lymphoblastic leukemia without CAR T‐cell‐related encephalopathy syndrome or severe cytokine release syndrome
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25630
HemoTypeSC Demonstrates >99% Field Accuracy in a Sickle Cell Disease Screening Initiative in Children of Southeastern Uganda
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25458
Haploidentical bone marrow transplantation improves cerebral hemodynamics in adults with sickle cell disease
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25455
Identifying leukemia‐associated immunophenotype‐based individualized minimal residual disease in acute myeloid leukemia and its prognostic significance
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25431
“Maximum tolerated dose” vs “fixed low‐dose” hydroxyurea for treatment of adults with sickle cell anemia
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25412
Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25550
Lower respiratory tract amyloidosis: Presentation, survival and prognostic factors. A multicenter consecutive case series
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25608
Third trimester and early postpartum period of pregnancy have the greatest risk for ACS in women with SCD
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25643
Oral ferroportin inhibitor VIT‐2763: First‐in‐human, phase 1 study in healthy volunteers
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25670
Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25688
The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly‐annotated patients with primary myelofibrosis
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25349
The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25676
Clinical and economic burden of regularly transfused adult patients with β‐thalassemia in the United States: A retrospective cohort study using payer claims
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25429
A prognostic index for nasal‐type early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25426
Purpura fulminans from reduced protein S following cytomegalovirus and varicella infection
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25386
Haploidentical transplantation in high‐risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25661
Early loss of immunity against measles following allogeneic hematopoietic stem cell transplantation
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25590
A confusing “white cell count”: Circulating micromegakaryocytes in post‐thrombocythemia myelofibrosis
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25377
Clinical outcomes with unfractionated heparin monitored by anti‐factor Xa vs. activated partial Thromboplastin time
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25565
Are eltrombopag plasma and skin hyperpigmentation related? The eyes have it
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25169
Unusual presentations of sitosterolemia limited to hematological abnormalities: A report of four cases presenting with stomatocytic anemia and thrombocytopenia with macrothrombocytes
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25427
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25558
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25633
Outcome and impact of post‐remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25332
Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25690
Safety of autologous stem cell transplantation in patients with known Human T‐cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25631
Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G‐CSF or G‐CSF and plerixafor mobilized grafts
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25672
Effect of novel agents on the risk of early death of newly diagnosed symptomatic multiple myeloma patients: A single Centre retrospective analysis
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25320
Extramedullary leukemia behaving as solid cancer: clinical, histologic, and genetic clues to chemoresistance in organ sites
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25594
Calculator‐free point‐of‐care prognostication in myelodysplastic syndromes
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25400
Unexpected babesiosis with dramatic morphological features
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25549
Be ever cautious until the truth is proven
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25410
Impact of natural neuromedin‐B receptor variants on iron metabolism
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25679
Predicting serum ferritin levels in patients with iron overload treated with the film‐coated tablet of deferasirox during the ECLIPSE study
来源期刊：American Journal of HematologyDOI：10.1002/ajh.25322
